---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-164018"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2026-04-20T23:59:59+00:00"
generated_at: "2026-05-15T05:22:59.777199+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# FibroBiologics regains full compliance with Nasdaq listing requirements; monitoring periods imposed

## Summary
- Nasdaq confirmed compliance with $2.5M stockholders' equity rule (Mar 9) and $1.00 bid price rule (Apr 17).
- One-year Mandatory Panel Monitor for both equity and bid price; failure during monitor triggers delist determination without cure period.
- Company remains listed on Nasdaq Capital Market under symbol FBLG; all prior listing matters closed.

## SEC filing metadata
- accession: 0001193125-26-164018
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2026-04-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000119312526164018/0001193125-26-164018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000119312526164018/fblg-20260309.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-164018
- JSON: https://secwatch.observer/filing/0001193125-26-164018.json
- Plain text: https://secwatch.observer/filing/0001193125-26-164018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.